The October 14 notice replaces the earlier July 7OH proposal. It describes Schedule I controls when 7OH or mitragynine pseudoindoxyl, alone or combined, exceeds 1 mg per gram in solids or 1 mg per milliliter in liquids, or when the mitragynine-to-covered-substances mass ratio is below 100:1.
The notice says a temporary order may be published on or after November 13, 2026. This research review did not establish that a subsequent 7OH order had been published by November 14. Read the live Federal Register record before making a possession, purchasing or business decision.
A separate August 26 order already covers mitragynine pseudoindoxyl, MGM-15 and MGM-16. The October notice states that the existing no-threshold pseudoindoxyl order remains in place until withdrawn or expired. A compound name matters; these actions are not interchangeable.